FDA Releases Draft Guidance on Estimating Safe Starting Dose for Clinical Trials

Summary

The Food and Drug Administration (FDA) has published a draft guidance outlining a process for determining a safe starting dose for new therapeutics in adult healthy volunteers in clinical trials, aiming to ensure the safety of human volunteers in initial trials.